Latest Oct-4 Stories
A paper published by Cell Press in the April 8th issue of the journal Cell Stem Cell reveals a new and more efficient method for reprogramming adult mouse and human cells into an embryonic stem cell-like state and could lead to better strategies for developing stem cells for therapeutic use.
New research shows that all not mammals are created equal.
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells.
A gene shown to play a role in the aging process appears to play a role in the regulation of the differentiation of embryonic stem cells.
Finding is expected to steer future work on therapies down the most efficient and promising paths.
A new technique for reprogramming human adult cells could greatly improve the safety and efficiency of producing patient-specific stem cells for use in a range of therapeutic applications to repair or replace damaged or diseased tissues.
In a breakthrough that may help fill a critical need in stem cell research and patient care, researchers at Mount Sinai School of Medicine have demonstrated that skin cells found in human amniotic fluid can be efficiently "reprogrammed" to pluripotency, where they have characteristics similar to human embryonic stem cells that can develop into almost any type of cell in the human body.
For years scientists have puzzled over to what extent the findings of studies on the embryonic stem cells (ES cells) of mice are transferable to humans.
SAN DIEGO, Feb. 4 /PRNewswire/ -- Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S.
SOUTH SAN FRANCISCO, Calif., Jan.
- Large; stout; burly.